Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA expands approval of breast cancer drug Kisqali
FDA expands approval of breast cancer drug Kisqali to earlier-stage patients
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease, drugmaker Novartis said Tuesday.
FDA Expands Use of Breast Cancer Drug Kisqali
While Verzenio, a drug in the same class, has been approved to lower the risk of early breast cancer returning, it's only for people with a very high risk of recurrence. Kisqali will be available to a much broader group of patients, whose disease may not be as aggressive at the time of diagnosis, Novartis said.
FDA awards Novartis expanded approval for breast cancer therapy
The potential market for the Novartis drug Kisqali could grow markedly, now that certain early-stage breast cancer patients will be able to receive it.
Novartis CEO says FDA's extended approval of breast cancer drug is a 'landmark' for the firm
Vas Narasimhan, CEO of Novartis, comments on the progress of the firm's Kisqali metastatic breast cancer drug after the company recently received an extended approval for it from the U.S. Food and Drug Administration.
Breast cancer drug Kisqali gets FDA approval to prevent cancer recurrence
The breast cancer drug Kisqali has received FDA approval to reduce cases of cancer recurrence. The drug was found to reduce the chances of a patient's breast cancer coming back by 25%.
FDA expanded their approval on drug cancer drug
First News
Novartis Wins FDA Approval of Kisqali for Early Breast Cancer
Novartis NVS announced that the FDA has approved breast cancer drug Kisqali (ribociclib) for a broader population. The regulatory body approved Kisqali in combination with an aromatase inhibitor (AI) for the adjuvant treatment of people with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) stage II and III early breast cancer (EBC) at high risk of recurrence,
1d
on MSN
Davis professor loses breast cancer battle months after community rallied to help find innovative therapies
Danielle Heard Mollel first shared her journey with stage 4 breast cancer with CBS13 in April. The Davis professor and mother ...
2d
Black Women Face Higher Death Risk From All Types of Breast Cancer
WEDNESDAY, Sept. 18, 2024 (HealthDay News) -- Black women have a higher risk of dying from any type of breast cancer than ...
Healthline
19h
Why ‘Get Organized’ Star Clea Shearer Feels ‘Lucky’ After Breast Cancer Treatment
Get Organized with the Home Edit” star Clea Shearer opens up about how she finds new meaning in life two years after being ...
12h
on MSN
Philadelphia breast cancer survivors train for historic rowing competition in Boston
A group of Philadelphia breast cancer survivors are getting ready for a big rowing competition, the first of its kind. These ...
1h
Senate president partners with UPMC, Bayer, others to host breast cancer screenings
Because Senate President Pro Tempore Kim Ward is a breast cancer survivor, she said she knows the importance of screening for ...
Cure Today
15h
Navigating the ‘Ever-Evolving Trajectory’ of Metastatic Breast Cancer
Through communication and education, patients with metastatic breast cancer may be able to balance treatment with quality of ...
16h
on MSN
Making Strides Against Breast Cancer Walk returns to Union Station!
Ava Clay was diagnosed with breast cancer eight years ago. Clay had a small lump that would grow and shrink each month, and ...
11h
WellSpan’s mammography van in York for breast cancer screenings
Next month is breast cancer awareness month, so expect to hear a lot about mammograms. But why wait? WellSpan’s mobile ...
21h
on MSN
Black women are more likely than white women to die of all types of breast cancer
Black women are more likely than white women to die from even the most treatable types of breast cancer, a study published ...
9h
5 for Good: Somerville mother runs Breast Cancer Goddess support group
Vera Ventura is deliberate about what she puts in her body. "Fruits and vegetables, organic fruits and vegetables," she said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Black women
Hina Khan
Kisqali
Novartis
Food and Drug Administration
Feedback